Study finds 30% of Wegovy, Saxenda users quit within 4 weeks
Saxenda was approved by the FDA for weight loss ... Blue Cross Blue Shield said the study showed younger patients, aged 18 to ...
pharmaphorum10d
Price cut leads NICE to back Novo Nordisk’s obesity drug Saxenda
Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management. The cost-effectiveness agency for England ...